|
Effect of Rehabilitation at Moderate Altitude on Airway Resistance Measured With Forced Oscillation Technique in COPD-patients
RECRUITINGN/ASponsored by Eastern Switzerland University of Applied Sciences
Actively Recruiting
PhaseN/A
SponsorEastern Switzerland University of Applied Sciences
Started2025-07-23
Est. completion2025-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07063563
Summary
Airway resistance will be measured using the forced oscillation technique (FOT). The parameters Rrs, Xrs, and ∆Xrs will be compared before and after a pulmonary rehabilitation cycle at moderate altitude. Additionally, the differences between low and moderate altitude will also be examined.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Aged ≥18 years * Stable clinical condition for \>3 weeks (e.g., no exacerbations) * Resting SpO₂ ≥88% and exercise-induced hypoxemia defined as a drop in SpO₂ of ≥4% and/or a level below 90% during the 6MWT * Informed consent documented by signature Exclusion Criteria: * Severe daytime resting hypoxemia (SpO₂ \<88%) * Long-term oxygen therapy * Unstable clinical condition requiring adjustment of pharmacological or other treatment modalities, need for intensive care, or presence of relevant severe comorbidities * Inability to comply with study procedures (e.g., due to language barriers, psychological disorders, neurological or orthopedic impairments, walking disability, or inability to ride a bicycle) * Women who are pregnant or breastfeeding * Enrolment in another clinical trial involving active treatment
Conditions1
COPD
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorEastern Switzerland University of Applied Sciences
Started2025-07-23
Est. completion2025-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07063563